Gilead Sciences (GILD) Raises Quarterly Dividend 2.8% to $0.73; 4.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Gilead Sciences (GILD) PT Lowered to $80 at Jefferies
February 2, 2022 8:15 AM ESTJefferies analyst Michael Yee lowered the price target on Gilead Sciences (NASDAQ: GILD) to $80.00 (from $85.00) while maintaining a Buy rating.
The analyst commented, "GILD says it is "excited" to also now look at an interim OS along with PFS, so investor focus... More
BMO Capital Lowers PT on Gilead (GILD) to $75 Following Earnings, Reiterates Focus on TROPiCS-02 Data Readout
February 2, 2022 5:20 AM ESTBMO Capital analyst Evan David Seigerman lowered the price target on Gilead Sciences (NASDAQ: GILD) to $75.00 (from $85.00) while maintaining a Outperform rating, following Q4 earnings release.
The analyst quotes: "Starting 2022 with a whimper: soft '22 guide, 4Q EPS miss, and a... More
BMO Capital Lowers PT on Gilead (GILD) to $75 Following Earnings, Reiterates Focus on TROPiCS-02 Data Readout
February 2, 2022 5:20 AM ESTBMO Capital analyst Evan David Seigerman lowered the price target on Gilead Sciences (NASDAQ: GILD) to $75.00 (from $85.00) while maintaining a Outperform rating, following Q4 earnings release.
The analyst quotes: "Starting 2022 with a whimper: soft '22 guide, 4Q EPS miss, and a... More

